(Press-News.org) Geneva, Switzerland, 17 April 2015 -- Almost one in four patients (24%) with advanced lung cancer in Europe, Asia and the US are not receiving EGFR test results before being started on treatment, researchers report at the European Lung Cancer Conference.
Medical Oncologist James Spicer from King's College London at Guy's Hospital, London, and colleagues studied how widely hospitals had implemented testing for mutations in the epidermal growth factor receptor gene among lung cancer patients.
Targeted therapies can more effectively treat cancers that are known to carry such mutations, Dr Spicer said. However anecdotal evidence had suggested the tests required to clarify a patient's status were not always been conducted, Dr Spicer said.
"The arrival of a new group of targeted EGFR inhibitors for the treatment of lung cancer driven by mutations in the EGFR gene has brought with it a new requirement for diagnostic laboratories to implement genetic testing," he explained. "For many institutions this has represented a significant departure from traditional pathology, which had previously focused only on microscopic examinations of tumour tissue."
"The new skills and investment required to deliver this new molecular pathology have understandably taken time to become universally available. Furthermore, the new clinical data underlying these developments has mandated a change in clinical practice, particularly the adoption of new treatment approaches in newly diagnosed patients?, and these changes have been adopted with variable speed around the world."
Ideally, all patients with non-small cell lung cancer of non-squamous ?histology who are fit for treatment of advanced disease should undergo EGFR mutation tests, Dr Spicer explained. This should be done in a timely manner so as not to delay first line treatment choices.
To examine the real-world situation, he and colleagues conducted an online survey of 562 oncologists in 10 countries (Canada, France, Germany, Italy, Japan, South Korea, Spain, Taiwan, UK and USA) between December 2014 and January 2015.
"We found that globally almost one in four patients are tested but results are not available at the time the treatment decision is made," Dr Spicer said.
"Not only were some suitable patients not ?tested at all for tumour EGFR mutations, some patients did undergo testing, but the treatment decision about whether to give an EGFR inhibitor or chemotherapy as first line treatment was taken without reference to the result."
For some patients, not being tested may adversely affect their treatment outcomes, Dr Spicer said. "Indeed, some recent clinical trial evidence suggests that this may even be compromising access to treatment that is associated with an overall survival benefit."
Commenting on the study, Professor Silvia Novello from the Department of Oncology at the University of Turin, Italy, said a particular strength of the study was its international nature. She said it was interesting that the authors were able to show that EGFR mutation testing was requested prior to first line therapy in 81% of patients with stage IIIb/IV non-small cell lung cancer and that results were demonstrated to be available before administration of treatment in 77% of cases. She noted that interpretation of the findings is limited by the fact that it is a survey-based report rather than an observational trial.
Respondents to the survey said a lack of sufficient tissue, a long turn-around time for testing and the poor performance status of the patient were among the reasons for non-testing and non respecting completely the IASLC guidelines. "The first two reasons are partially related to an incomplete integration of multidisciplinary oncology teams, while the third one can be attributed to an imperfect knowledge of data regarding the use of EGFR inhibitors," Professor Novello said.
INFORMATION:
Recent research published in The Diabetes Educator by Dr. Shiela Strauss, associate professor of nursing and co-director of the Statistics and Data Management Core for NYU's Colleges of Nursing and Dentistry, along with a team of NYU researchers, reveals differing perceptions among adult populations at-risk for diabetes that may offer new approaches to diabetes education and prevention.
"We found that there are differences in the perceptions of those who are at risk for diabetes that depend on the specific characteristics that place them at risk," said Strauss.
Illness ...
A team from Disney Research and Carnegie Mellon University have devised a 3-D printer that layers together laser-cut sheets of fabric to form soft, squeezable objects such as bunnies, doll clothing and phone cases. These objects can have complex geometries and incorporate circuitry that makes them interactive.
"Today's 3-D printers can easily create custom metal, plastic, and rubber objects," said Jim McCann, associate research scientist at Disney Research Pittsburgh. "But soft fabric objects, like plush toys, are still fabricated by hand. Layered fabric printing is one ...
Disney Research has demonstrated that battery-free, radio frequency identification (RFID) tags can be used to cheaply and unobtrusively determine how people use and interact with daily objects, enabling new types of interactive play, smart homes and work environments, and new methods for studying consumer shopping habits.
RFID tags are designed to simply report an identifying code when energized by an RFID reader, but a Disney Research team directed by Dr. Alanson Sample showed that the radio frequency signals transmitted by these tags provide a unique RF signature which ...
An international team of scientists have put forward a blueprint for a purely space-based system to solve the growing problem of space debris. The proposal, published in Acta Astronautica, combines a super-wide field-of-view telescope, developed by RIKEN's EUSO team, which will be used to detect objects, and a recently developed high-efficiency laser system, the CAN laser that was presented in Nature Photonics in 2013, that will be used to track space debris and remove it from orbit.
Space debris, which is continuously accumulating as a result of human space activities, ...
Half of all patients who survive a cardiac arrest experience problems with cognitive functions such as memory and attention. This has been shown by a major international study led from Lund University. Surprisingly, however, a control group comprising heart attack patients had largely the same level of problems. This suggests that it is not only the cardiac arrest and the consequent lack of oxygen to the brain that is the cause of the patients' difficulties.
The study led by Lund University involved 950 cardiac arrest patients in Europe and Australia. Six months after ...
This news release is available in Japanese.
It seems unnatural that a species could survive without having sex. Yet over the ages, evolution has endowed females of certain species of amphibians, reptiles and fish with the ability to clone themselves, and perpetuate offspring without males. Researchers at the at the Okinawa Institute of Science and Technology Graduate University (OIST) found that in species where females have evolved the ability to reproduce without males relatively recently, fertilization is still ensuring the survival of the maximum number of healthy ...
Scientists at the Vetmeduni Vienna investigated whether stomach ulcers in cattle are related to the presence of certain bacteria. For their study, they analyzed bacteria present in healthy and ulcerated cattle stomachs and found very few differences in microbial diversity. Bacteria therefore appear to play a minor role in the development of ulcers. The microbial diversity present in the stomachs of cattle has now for the first time been published in the journal Veterinary Microbiology.
Gastritis and stomach ulcers in humans are often caused by the bacterium Helicobacter ...
Breast cancer patients often display mild cognitive defects even before the initiation of chemotherapy. A new study by Ludwig-Maximilians-Universitaet (LMU) in Munich researchers now attributes the syndrome to post-traumatic stress induced by diagnosis of the disease.
A large number of studies have shown that cancer patients very often exhibit mild deficits of attention, memory and other basic cognitive functions. The phenomenon has generally been attributed to putative side-effects of chemotherapeutic drugs on the brain, and the condition is therefore popularly referred ...
WASHINGTON --Droperidol is safe and effective for calming violent and aggressive emergency patients, and the negative effects that garnered a black box warning from the Food and Drug Administration (FDA) are actually quite rare. A new study of the once ubiquitous, now scarce, sedating agent was published online Wednesday in Annals of Emergency Medicine ("The Safety and Effectiveness of Droperidol for Sedation of Acute Behavioral Disturbance in the Emergency Department").
"In our study, the two side effects that led to the black box warning - QT prolongation and torsades ...
CLEVELAND -- Anthony J. Furlan, MD, Chairman of Neurology and Co-Director of the Neurological Institute at University Hospitals (UH) Case Medical Center and Case Western Reserve University School of Medicine, who writes an accompanying editorial for five studies about endovascular stroke therapy published simultaneously in the New England Journal of Medicine (NEJM.org April 17), says these randomized clinical trials represent a breakthrough in showing the benefits of endovascular therapy for acute ischemic strokes.
"Now even endovascular skeptics will be convinced," Dr. ...
